Per Lindmarker

4.3k total citations · 1 hit paper
25 papers, 3.1k citations indexed

About

Per Lindmarker is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Per Lindmarker has authored 25 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Hematology. Recurrent topics in Per Lindmarker's work include Venous Thromboembolism Diagnosis and Management (16 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Per Lindmarker is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Per Lindmarker collaborates with scholars based in Sweden, United Kingdom and Canada. Per Lindmarker's co-authors include Sam Schulman, Hans Johnsson, A. Juhlin‐Dannfelt, Ary Ribeiro, L. Jorfeldt, Margareta Holmström, Anders Carlsson, Peter Nicol, Gerd Lärfars and S. Granqvist and has published in prestigious journals such as New England Journal of Medicine, Circulation and PLoS ONE.

In The Last Decade

Per Lindmarker

25 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism

1995 665 citations Sam Schulman, Per Lindmarker et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per Lindmarker Sweden	16	2.6k	2.0k	992	690	407	25	3.1k
H.R. Büller Netherlands	22	2.1k 0.8×	1.5k 0.7×	873 0.9×	916 1.3×	258 0.6×	50	2.8k
Harry R. Büller Netherlands	18	1.6k 0.6×	1.1k 0.6×	552 0.6×	582 0.8×	208 0.5×	28	2.3k
Angelo Ghirarduzzi Italy	24	2.1k 0.8×	1.6k 0.8×	1.2k 1.2×	706 1.0×	310 0.8×	61	3.1k
Maria M.W. Koopman Netherlands	21	2.1k 0.8×	1.3k 0.7×	1.1k 1.1×	853 1.2×	162 0.4×	48	3.2k
Mashio Nakamura Japan	28	2.6k 1.0×	2.2k 1.1×	398 0.4×	851 1.2×	481 1.2×	151	3.6k
Raffaele Pesavento Italy	21	1.9k 0.7×	1.6k 0.8×	544 0.5×	549 0.8×	611 1.5×	61	2.5k
Christine Demers Canada	24	2.5k 0.9×	2.5k 1.3×	985 1.0×	1.2k 1.8×	191 0.5×	37	3.8k
Davide Imberti Italy	27	2.0k 0.8×	1.3k 0.6×	453 0.5×	743 1.1×	264 0.6×	82	2.4k
Melissa Forgie Canada	11	1.9k 0.7×	939 0.5×	605 0.6×	752 1.1×	199 0.5×	16	2.8k
Lori‐Ann Linkins Canada	27	2.2k 0.8×	1.4k 0.7×	703 0.7×	1.4k 2.0×	141 0.3×	64	3.0k

Countries citing papers authored by Per Lindmarker

Since Specialization

Citations

This map shows the geographic impact of Per Lindmarker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lindmarker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lindmarker more than expected).

Fields of papers citing papers by Per Lindmarker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Lindmarker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lindmarker. The network helps show where Per Lindmarker may publish in the future.

Co-authorship network of co-authors of Per Lindmarker

This figure shows the co-authorship network connecting the top 25 collaborators of Per Lindmarker. A scholar is included among the top collaborators of Per Lindmarker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Lindmarker. Per Lindmarker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindmarker, Per, et al.. (2021). Emergency department crowding and mortality in 14 Swedish emergency departments, a cohort study leveraging the Swedish Emergency Registry (SVAR). PLoS ONE. 16(3). e0247881–e0247881. 24 indexed citations

Göransson, Katarina E., et al.. (2012). Patients’ pathway to emergency care. European Journal of Emergency Medicine. 20(1). 45–50. 14 indexed citations

Ekelund, Ulf, et al.. (2011). Patient throughput times and inflow patterns in Swedish emergency departments. A basis for ANSWER, A National SWedish Emergency Registry. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 19(1). 37–37. 24 indexed citations

Schulman, Sam, Per Lindmarker, Margareta Holmström, et al.. (2006). Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Journal of Thrombosis and Haemostasis. 4(4). 734–742. 362 indexed citations

Wiman, B., Per Lindmarker, Margareta Sten-Linder, et al.. (2005). Evaluation of low PAI‐1 activity as a risk factor for hemorrhagic diathesis. Journal of Thrombosis and Haemostasis. 4(1). 201–208. 38 indexed citations

Lindmarker, Per, et al.. (2003). Helicobacter pylori causes gastrointestinal hemorrhage in patients with congenital bleeding disorders. Thrombosis and Haemostasis. 89(4). 741–746. 8 indexed citations

Schulman, Sam, Nils Kinnman, Per Lindmarker, & Madeleine von Sydow. (2002). A randomized study of alpha‐interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders. Haemophilia. 8(2). 129–135. 11 indexed citations

Schulman, Sam & Per Lindmarker. (2000). Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism. New England Journal of Medicine. 342(26). 1953–1958. 270 indexed citations

Lindmarker, Per, et al.. (2000). The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. Journal of Internal Medicine. 247(5). 601–606. 33 indexed citations

10.

Ribeiro, Ary, Per Lindmarker, Hans Johnsson, A. Juhlin‐Dannfelt, & L. Jorfeldt. (1999). Pulmonary embolism: a follow‐up study of the relation between the degree of right ventricle overload and the extent of perfusion defects. Journal of Internal Medicine. 245(6). 601–610. 32 indexed citations

11.

Lindmarker, Per. (1999). Can All Patients with Deep Vein Thrombosis Receive Low-Molecular-Weight Heparin in an Outpatient Setting?. Pathophysiology of Haemostasis and Thrombosis. 29(Suppl. 1). 84–88. 5 indexed citations

12.

Ribeiro, Ary, Per Lindmarker, A. Juhlin‐Dannfelt, Hans Johnsson, & L. Jorfeldt. (1997). Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate. American Heart Journal. 134(3). 479–487. 385 indexed citations

13.

Schulman, Sam, S. Granqvist, Margareta Holmström, et al.. (1997). The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism. New England Journal of Medicine. 336(6). 393–398. 424 indexed citations

14.

Norén, Anders, Per Lindmarker, & Stefan Rosfors. (1997). A Retrospective Follow-up Study of Patients with Suspected Deep Vein Thrombosis and Negative Results of Colour Duplex Ultrasound. Phlebology The Journal of Venous Disease. 12(2). 56–59. 4 indexed citations

15.

Schulman, Sam, Per Lindmarker, Anders Carlsson, et al.. (1996). A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism. Obstetrical & Gynecological Survey. 51(1). 29–30. 36 indexed citations

16.

Lindmarker, Per, et al.. (1996). Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis A feasibility and health economic study in an outpatient setting. Journal of Internal Medicine. 240(6). 395–401. 79 indexed citations

17.

Schulman, Sam, Per Lindmarker, Anders Carlsson, et al.. (1995). A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism. New England Journal of Medicine. 332(25). 1661–1665. 665 indexed citations breakdown →

18.

Schulman, Sam, Per Lindmarker, & Hans Johnsson. (1995). Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism. Blood Coagulation & Fibrinolysis. 6(4). 311–316. 8 indexed citations

19.

Lindmarker, Per, Margareta Holmström, S. Granqvist, Hans Johnsson, & D. Lockner. (1994). Comparison of Once-Daily Subcutaneous Fragmin® with Continuous Intravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis. Thrombosis and Haemostasis. 72(2). 186–190. 169 indexed citations

20.

Schulman, Sam, Hans Johnsson, & Per Lindmarker. (1991). Thrombotic Complications after Substitution with a FVII Concentrate. Thrombosis and Haemostasis. 66(5). 619–619. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact